Form 8-K - Current report:
SEC Accession No. 0001104659-26-066345
Filing Date
2026-05-26
Accepted
2026-05-26 17:09:58
Documents
13
Period of Report
2026-05-22
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2615554d1_8k.htm   iXBRL 8-K 26830
2 EXHIBIT 5.1 tm2615554d1_ex5-1.htm EX-5.1 17344
3 GRAPHIC tm2615554d1_ex5-1img001.jpg GRAPHIC 3911
  Complete submission text file 0001104659-26-066345.txt   217871

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA tmb-20260522.xsd EX-101.SCH 3011
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tmb-20260522_lab.xml EX-101.LAB 34239
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tmb-20260522_pre.xml EX-101.PRE 22357
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2615554d1_8k_htm.xml XML 3081
Mailing Address 12 PENNS TRAIL NEWTOWN PA 18940
Business Address 12 PENNS TRAIL NEWTOWN PA 18940 267-759-3680
Traws Pharma, Inc. (Filer) CIK: 0001130598 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36020 | Film No.: 261021014
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)